Articles From: A 401(k) Rollover Checklist to Alcobra Ltd. to Present at the Gordon Research Conference on Fragile X and Autism-Related Disorders


2014/08/24
Is deciding what to do with an orphan 401(k) on your to-do list? Here are seven steps for getting it done.
Sign-up for A 401(k) Rollover Checklist investment picks
2011/04/12
See what we recommend for risk-averse ETF investors.
Sign-up for A Conservative ETF Portfolio for Retirees investment picks
2011/09/15
See what we recommend for risk-averse ETF investors.
Sign-up for A Conservative ETF Portfolio for Retirees investment picks
2014/08/17
In a fully valued market, there are worse things than buying wide-moat names at decent discounts.
Sign-up for A Few Picks to Tide Over the Bargain-Hunters investment picks
2012/04/13
AQR's Michael Mendelson touts the advantages of commodities and leverage as they tend to provide a greater reward in his fund for the same level of risk as in traditional portfolios.
Sign-up for A Less Risky Way of Taking On Risk? investment picks
2014/08/15
We prefer the yield, stability, and growth prospects of the triple-net structure over RIDEA.
Sign-up for A Matter of Time for Health-Care REITs investment picks
2011/04/12
See what we recommend for risk-averse ETF investors with a 15- to 20-year time horizon.
Sign-up for A Moderate ETF Portfolio for Retirees investment picks
2011/09/15
See what we recommend for risk-averse ETF investors with a 15- to 20-year time horizon.
Sign-up for A Moderate ETF Portfolio for Retirees investment picks
ANN ARBOR, Mich., May 15, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) , the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today reported financial results for the quarter ended March 31, 2014.
Sign-up for Aastrom Biosciences Reports First-Quarter 2014 Financial Results investment picks
ANN ARBOR, Mich., May 9, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) , the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, announces the following webcast: If you are unable to participate during the live call, the webcast will be available at http://investors.aastrom.com/events.cfm until May 15, 2015.
Sign-up for Aastrom Biosciences to Host First Quarter 2014 Investor Call on May 15, 2014 investment picks
2014/7/8
By Ian Walker LONDON--
Sign-up for AbbVie raises offer for Shire investment picks
DANVERS, Mass., May 21, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD) , a leading provider of breakthrough heart support technologies, today announced it has received approval for implementation of a Continuous Access Protocol (CAP) from the Food & Drug Administration (FDA) for RECOVER RIGHT, an Investigational Device Exemption (IDE) study of the Impella® RP (Right Peripheral) System.
Sign-up for Abiomed Receives Continuous Access Protocol (CAP) for RECOVER RIGHT Impella RP Study investment picks
DANVERS, Mass., May 19, 2014 (GLOBE NEWSWIRE) -- Abiomed Inc .
Sign-up for Abiomed's Impella(R) Technology Showcased at EuroPCR 2014 investment picks
LAVAL, Quebec, May 21, 2014 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (" Acasti " or the " Corporation ") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of certain cardiometabolic disorders, announces its consolidated financial results for the fourth quarter and fiscal year ended February 28, 2014.
Sign-up for Acasti Announces Fourth Quarter and Fiscal Year Results investment picks
SUNNYVALE, Calif., May 19, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY) , announced today that its management is scheduled to present at the 2014 Jefferies Global Healthcare Conference in New York City on Tuesday, June 3, 2014 at 3 p.m. ET/ 12 p.m. PT.
Sign-up for Accuray Incorporated to Present at 2014 Jefferies Global Healthcare Conference investment picks
SOUTH SAN FRANCISCO, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq:AKAO) , a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR) gram-negative infections, today reported financial results for the quarter ended March 31, 2014.
Sign-up for Achaogen Announces First Quarter 2014 Results investment picks
LOS ANGELES, May 21, 2014 (GLOBE NEWSWIRE) -- Global Eagle Entertainment Inc. (Nasdaq:ENT) today announced that it has appointed network services expert Aditya Chatterjee as Chief Technology Officer (CTO) and Senior Vice President of Engineering.
Sign-up for Aditya Chatterjee Joins Global Eagle Entertainment as Chief Technology Officer and SVP of Engineering investment picks
BALTIMORE, May 8, 2014 (GLOBE NEWSWIRE) -- Advanced Radiology, the premier provider of imaging services in the Baltimore Metropolitan Area, and our affiliate RadNet, Inc. (Nasdaq:RDNT) , announced a formal partnership to provide imaging services to the Baltimore Ravens.
Sign-up for Advanced Radiology and RadNet, Inc. Announces Partnership With the Baltimore Ravens investment picks
PRINCETON, N.J., May 13, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS) , a biotechnology company developing cancer immunotherapies, announced that principal investigator Nicola Mason, BVet.Med, PhD, DACVIM, of the University of Pennsylvania School of Veterinary Medicine, will present updated data from the ongoing ADXS-cHER2 study in canine osteosarcoma at the 2014 American College of Veterinary Internal Medicine (ACVIM) Forum on Thursday, June 5 th at 4:25-5:15 p.m.in Nashville, TN.
Sign-up for Advaxis Principal Investigator to Present ADXS-cHER2 Data in Canine Osteosarcoma at American College of Veterinary Internal Medicine Forum investment picks
CAMBRIDGE, Mass., May 7, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) , a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, today announced that on May 1, 2014, Aegerion granted stock options to purchase an aggregate of 27,750 shares of common stock to 16 new employees under the inducement stock option program described below.
Sign-up for Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program investment picks
2014/5/22
SACRAMENTO, Calif., May 22, 2014 (GLOBE NEWSWIRE) -- Aerojet Rocketdyne, a GenCorp (NYSE:GY) company, played a significant role in successfully launching a national security payload into orbit for the U.S. government.
Sign-up for Aerojet Rocketdyne Propulsion Supported United Launch Alliance's Successful Atlas V Mission for the U.S. Government investment picks
2014/5/22
SACRAMENTO, Calif., May 22, 2014 (GLOBE NEWSWIRE) -- Aerojet Rocketdyne, a GenCorp (NYSE:GY) company, announced today that its propulsion systems successfully contributed to the intercept of a virtual target during the first test of Raytheon's Standard Missile-3 (SM-3) Block IB guided missile from the Aegis Ashore weapon system.
Sign-up for Aerojet Rocketdyne Supports Inaugural Standard Missile-3 Block IB Guided Missile Aegis Ashore Launch investment picks
SACRAMENTO, Calif., May 17, 2014 (GLOBE NEWSWIRE) -- Aerojet Rocketdyne, a GenCorp (NYSE:GY) company, has supported the successful launch of the sixth Global Positioning System (GPS) IIF military navigation satellite into orbit today.
Sign-up for Aerojet Rocketdyne Supports Successful Launch of Global Positioning System Satellite for the U.S. Air Force investment picks
SACRAMENTO, Calif., May 19, 2014 (GLOBE NEWSWIRE) -- Aerojet Rocketdyne, a GenCorp (NYSE:GY) company, has received a contract from Stratolaunch Systems Corporation (SSC) to provide six RL10C-1 production engines, with an option to provide an additional six RL10C-1 production engines at a later date, for the third stage of a revolutionary commercial air-launch system.
Sign-up for Aerojet Rocketdyne to Provide Upper-Stage Propulsion for Revolutionary Eagles Launch System investment picks
SUNNYVALE, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- Alliance Fiber Optic Products, Inc. (Nasdaq:AFOP) , an innovative supplier of fiber optic components, subsystems, and integrated modules for the optical network equipment market, today announced that Mr.
Sign-up for AFOP to Present at B. Riley & Co. 15th Annual Investor Conference May 20, 2014 investment picks
DENVER, May 8, 2014 (GLOBE NEWSWIRE) -- Air Methods Corporation (Nasdaq:AIRM) , the global leader in air medical transportation, reported financial results for the quarter ended March 31, 2014 and provided an update on April 2014 flight volume.
Sign-up for Air Methods Reports 1Q2014 Results and 2Q2014 Update investment picks
THOROFARE, N.J., May 14, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (AIM:AKR.L) (Nasdaq:AKER) , (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and testing products, reports its financial results for the first quarter ended March 31, 2014.
Sign-up for Akers Biosciences Announces Its Financial Results for First Quarter 2014 investment picks
THOROFARE, N.J., May 16, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) , (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and testing products, entered into an agreement (the "Agreement") with Jai Capital LLC ("Jai"), a Nevada company specializing in market development, distribution, and joint ventures of medical devices in India, to market the Company's PIFA Heparin/Platelet Factor-4 Rapid Assay, PIFA Dengue Assay, Battlefield Blood Transfusion Card and Tri-Cholesterol rapid tests.
Sign-up for Akers Biosciences Signs Agreement to Market Rapid Tests in India investment picks
TEL AVIV, Israel, May 15, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd.
Sign-up for Alcobra Announces First Quarter Financial Results and Corporate Update investment picks
TEL AVIV, Israel, May 23, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd.
Sign-up for Alcobra Ltd. to Present at the Gordon Research Conference on Fragile X and Autism-Related Disorders investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: A 401(k) Rollover Checklist to Alcobra Ltd. to Present at the Gordon Research Conference on Fragile X and Autism-Related Disorders
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry